ArticleFrontiers in immunology2021

A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities.

Xiaopei Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.